Pancreatic Cancer Research

ResearcherSir Run Run Shaw HospitalNo recent work listed

Mingjie Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3193-7694; OpenAlex author ID A5100350853. Sources: OpenAlex.

Their work

Papers
6
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2018: 2 papers · 2019: 3 papers · 2020: 1 paper

Papers 6

  1. Interferon gamma inhibits CXCL8-CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer. Co-author DOI 10.1136/jitc-2019-000308↗
  2. The distinct role of CD73 in the progression of pancreatic cancer. Co-author DOI 10.1007/s00109-018-01742-0↗
  3. IFN-γ down-regulates the PD-1 expression and assist nivolumab in PD-1-blockade effect on CD8+ T-lymphocytes in pancreatic cancer. Co-author DOI 10.1186/s12885-019-6145-8↗
  4. Down-regulation of miR-30a-5p is Associated with Poor Prognosis and Promotes Chemoresistance of Gemcitabine in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.7150/jca.31191↗
  5. Interferon Gamma Inhibits CXCL8-Induced Proliferation and Migration of Pancreatic Cancer BxPC-3 Cell Line via a RhoGDI2/Rac1/NF-κB Signaling Pathway. Co-author DOI 10.1089/jir.2018.0070↗
  6. Asparaginyl endopeptidase enhances pancreatic ductal adenocarcinoma cell invasion in an exosome-dependent manner and correlates with poor prognosis. Co-author DOI 10.3892/ijo.2018.4318↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Guoping Ding · 5 shared papers, 2018–2020 · strength 0.51
  2. Liping Cao · 5 shared papers, 2018–2020 · strength 0.51
  3. Liangjing Zhou · 3 shared papers, 2018–2019 · strength 0.29
  4. Shengnan Jia · 3 shared papers, 2018–2019 · strength 0.29
  5. Tao Shen · 2 shared papers, 2019–2020 · strength 0.22
  6. Zhengrong Wu · 2 shared papers, 2019 · strength 0.20
  7. Weihua Yu · 2 shared papers, 2019 · strength 0.20
  8. Xiaodong Xu · 2 shared papers, 2018–2020 · strength 0.19
  9. Xu Dong Sun · 2 shared papers, 2018–2020 · strength 0.18
  10. Qiang Yan · 2 shared papers, 2018–2020 · strength 0.18
  11. Zhengrong Wu · 1 shared paper, 2019 · strength 0.11
  12. Ting Zhao · 1 shared paper, 2018 · strength 0.09
  13. Zhihong Ma · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.